(Bloomberg) -- Johnson & Johnson shares tumbled after the company said profit margins in its medical device and technology unit fell last quarter and drug sales will be lower in the second half of the year than the first.Most Read from BloombergChina Weighs Stock Market Rescue Package Backed by $278 BillionNetflix Pays $5 Billion for ‘Raw’ in Bet on Live EventsAn Isolated Israel Doubles Down on War in Gaza — At All CostsIndia Tops Hong Kong as World’s Fourth-Largest Stock MarketHong Kong Stocks

Related Keywords

Texas , United States , Boston , Massachusetts , New York , Gerry Smith , Mizuho Jared Holz , Bloomberg Johnson , Joe Wolk , Vijay Kumar , Bloomberg Businessweek , Boston Scientific , Kenvue Inc , Boston Scientific Corp , Abbott Laboratories , Bloomberg , Inflation Reduction Act , Jared Holz , Chief Financial Officer Joe Wolk , New Brunswick , New Jersey Based , Pharma Sales , Bloomberg Tv , Ohnson Johnson ,